vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $78.6M, roughly 1.1× Repay Holdings Corp). BillionToOne, Inc. runs the higher net margin — 6.8% vs -178.3%, a 185.1% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 0.4%). Repay Holdings Corp produced more free cash flow last quarter ($23.2M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
BLLN vs RPAY — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $78.6M |
| Net Profit | $5.7M | $-140.1M |
| Gross Margin | 69.9% | 74.2% |
| Operating Margin | 11.5% | -182.2% |
| Net Margin | 6.8% | -178.3% |
| Revenue YoY | 117.4% | 0.4% |
| Net Profit YoY | 138.3% | -3304.1% |
| EPS (diluted) | $0.10 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $78.6M | ||
| Q3 25 | $83.5M | $77.7M | ||
| Q2 25 | — | $75.6M | ||
| Q1 25 | — | $77.3M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | $38.4M | $79.1M | ||
| Q2 24 | — | $74.9M | ||
| Q1 24 | — | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $5.7M | $-6.4M | ||
| Q2 25 | — | $-102.3M | ||
| Q1 25 | — | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-14.9M | $3.2M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | 69.9% | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | 52.6% | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
| Q4 25 | — | -182.2% | ||
| Q3 25 | 11.5% | -3.9% | ||
| Q2 25 | — | -138.7% | ||
| Q1 25 | — | -4.7% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | -32.9% | -0.9% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | 6.8% | -8.3% | ||
| Q2 25 | — | -135.2% | ||
| Q1 25 | — | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | -38.8% | 4.1% | ||
| Q2 24 | — | -5.4% | ||
| Q1 24 | — | -6.5% |
| Q4 25 | — | $-1.68 | ||
| Q3 25 | $0.10 | $-0.08 | ||
| Q2 25 | — | $-1.15 | ||
| Q1 25 | — | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | $-1.47 | $0.03 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $115.7M |
| Total DebtLower is stronger | $55.0M | $280.1M |
| Stockholders' EquityBook value | $-239.5M | $484.4M |
| Total Assets | $327.5M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $115.7M | ||
| Q3 25 | $195.2M | $95.7M | ||
| Q2 25 | — | $162.6M | ||
| Q1 25 | — | $165.5M | ||
| Q4 24 | — | $189.5M | ||
| Q3 24 | — | $168.7M | ||
| Q2 24 | — | $147.1M | ||
| Q1 24 | — | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | $55.0M | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | — | $484.4M | ||
| Q3 25 | $-239.5M | $616.9M | ||
| Q2 25 | — | $633.7M | ||
| Q1 25 | — | $755.7M | ||
| Q4 24 | — | $761.3M | ||
| Q3 24 | $-242.9M | $754.7M | ||
| Q2 24 | — | $815.4M | ||
| Q1 24 | — | $813.8M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $327.5M | $1.3B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $23.3M |
| Free Cash FlowOCF − Capex | $6.5M | $23.2M |
| FCF MarginFCF / Revenue | 7.7% | 29.6% |
| Capex IntensityCapex / Revenue | 8.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $23.3M | ||
| Q3 25 | $13.8M | $32.2M | ||
| Q2 25 | — | $33.1M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | — | $60.1M | ||
| Q2 24 | — | $31.0M | ||
| Q1 24 | — | $24.8M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $6.5M | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
| Q4 25 | — | 29.6% | ||
| Q3 25 | 7.7% | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 8.8% | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
